Page last updated: 2024-10-21

5,7-dichlorokynurenic acid and Nerve Degeneration

5,7-dichlorokynurenic acid has been researched along with Nerve Degeneration in 3 studies

5,7-dichlorokynurenic acid: potent antagonist at the N-methyl-D-aspartate receptor-associated glycine binding site

Nerve Degeneration: Loss of functional activity and trophic degeneration of nerve axons and their terminal arborizations following the destruction of their cells of origin or interruption of their continuity with these cells. The pathology is characteristic of neurodegenerative diseases. Often the process of nerve degeneration is studied in research on neuroanatomical localization and correlation of the neurophysiology of neural pathways.

Research Excerpts

ExcerptRelevanceReference
"Memantine, an N-methyl-D-aspartate (NMDA) receptor antagonist, reduces the clinical deterioration in moderate-to-severe Alzheimer disease (AD) for which other treatments are not available."3.72Memantine inhibits and reverses the Alzheimer type abnormal hyperphosphorylation of tau and associated neurodegeneration. ( Grundke-Iqbal, I; Haque, N; Iqbal, K; Li, L; Sengupta, A, 2004)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, L1
Sengupta, A1
Haque, N1
Grundke-Iqbal, I1
Iqbal, K1
Wu, SZ1
Jiang, S1
Sims, TJ1
Barger, SW1
Boireau, A1
Malgouris, C1
Burgevin, MC1
Pény, C1
Durand, G1
Bordier, F1
Meunier, M1
Miquet, JM1
Daniel, M1
Chevet, T1
Jimonet, P1
Mignani, S1
Blanchard, JC1
Doble, A1

Other Studies

3 other studies available for 5,7-dichlorokynurenic acid and Nerve Degeneration

ArticleYear
Memantine inhibits and reverses the Alzheimer type abnormal hyperphosphorylation of tau and associated neurodegeneration.
    FEBS letters, 2004, May-21, Volume: 566, Issue:1-3

    Topics: 2-Amino-5-phosphonovalerate; Alzheimer Disease; Animals; Calcium-Calmodulin-Dependent Protein Kinase

2004
Schwann cells exhibit excitotoxicity consistent with release of NMDA receptor agonists.
    Journal of neuroscience research, 2005, Mar-01, Volume: 79, Issue:5

    Topics: 2-Amino-5-phosphonovalerate; Analysis of Variance; Animals; Calcium; Cell Death; Cells, Cultured; Cu

2005
Neuroprotective effects of RPR 104632, a novel antagonist at the glycine site of the NMDA receptor, in vitro.
    European journal of pharmacology, 1996, Apr-11, Volume: 300, Issue:3

    Topics: Aminoquinolines; Animals; Benzothiadiazines; Binding, Competitive; Cerebral Cortex; Cyclic GMP; Exci

1996